Holding(s) in Company
17 Dezember 2008 - 2:20PM
UK Regulatory
RNS Number : 3109K
York Pharma plc
17 December 2008
TR-1: Notifications of Major Interests in Shares
1. Identity of the issuer or the underlying issuer
of existing shares to which voting rights are
attached: York Pharma plc
2. Reason for notification (yes/no)
An acquisition or disposal of voting rights
An acquisition or disposal of financial instruments which may result in
the acquisition of shares already issued to which voting rights are
attached
An event changing the breakdown of voting rights
X
Other (please specify): Dilution due to share capital increase
3. Full name of person(s) 1. Awal Trust Company Limited (as "parent undertaking" of Awal
subject to notification Bank B.S.C. [Awal] and Saad Investments Company Ltd [SICL])
obligation:
2. Maan Abdulwahed Al-Sanea (as "parent undertaking" of Awal and
SICL)
4. Full name of shareholder(s) Vidacos Nominees Pty Ltd. (as nominee for Awal) and
(if different from 3):
Bear Stearns Securities Corp (as nominee for SICL)
5. Date of transaction (and n/a
date on which the threshold is
crossed or reached if
different):
6. Date on which issuer 16 December 2008
notified:
7. Threshold(s) that is/are 21% threshold was crossed, down to 20%
crossed or reached:
8: Notified Details
A: Voting rights attached to shares
Class/type of shares Situation previous to the triggering Resulting situation after the triggering transaction
If possible use ISIN code transaction
Number of shares Number of voting Number of shares Number of voting Percentage of voting
rights rights rights
Direct Indirect Direct Indirect
GB00B00QHC86 12,367,399 12,367,399 12,367,399 Nil 12,367,399 Nil 20.32%
B: Financial Instruments
Resulting situation after the triggering transaction
Type of financial instrument Expiration date Exercise/ conversion No. of voting rights Percentage of voting
period/date that may be acquired rights
(if the instrument
exercised/converted)
- - - - -
Total (A+B)
Number of voting rights Percentage of voting rights
12,367,399 20.32%
9. Chain of controlled undertakings through which the voting rights and /or
the financial instruments are effectively held, if applicable:
Maan Abdulwahed Al-Sanea is subject to a notification obligation pursuant to
DTR 5.2.1(e) as a "parent undertaking" of Awal, the indirect holder of
8,558,699 shares, and as a "parent undertaking" of SICL, the indirect holder
of 3,808,700 shares; his joint holding amounts to 20.32%.
Awal and SICL are indirectly owned by Awal Trust Company Limited ("ATCL") as
trustee of the Saad STAR Trust. ATCL is therefore subject to notification
obligation pursuant to DTR 5.2.1(e) as a "parent undertaking" of Awal and
SICL.
Proxy Voting:
10. Name of proxy holder: -
11. Number of voting rights proxy holder will cease to hold: -
12. Date on which proxy holder will cease to hold voting rights: -
13. Additional information: Awal Bank D.S.C. indirectly holds 8,558,699
(14.06%) shares through Vidacos Nominees Pty
Ltd.
Saad Investments Company Limited indirectly
holds 3,808,700 (6.26%) shares through Bear
Stearn Securities Corp.
14 Contact name: Christopher C Hart
15. Contact telephone number : +41 22 715 0303
This information is provided by RNS
The company news service from the London Stock Exchange
END
HOLBXBDDUBBGGIR
York Pharma (LSE:YRK)
Historical Stock Chart
Von Mai 2024 bis Jun 2024
York Pharma (LSE:YRK)
Historical Stock Chart
Von Jun 2023 bis Jun 2024
Echtzeit-Nachrichten über York Pharma (Londoner Börse): 0 Nachrichtenartikel
Weitere York Pharma Plc News-Artikel